AYTU BIOPHARMA, INC — All Filings
890 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
10KSB
10QSB
10QSB/A
3
3/A
4
4/A
424B2
424B3
424B4
424B5
425
5
8-A12B
8-A12G
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEF 14C
DEFA14A
DEL AM
DRS
EFFECT
FWP
NT 10-K
NT 10-Q
POS AM
PRE 14A
PRE 14C
PRER14A
REGDEX
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-4
S-4/A
S-8
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-I
SC TO-I/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | FORM 8-K | 0001437749-25-016832 | May 14, 2025 | — |
| 10-Q | FORM 10-Q | 0001437749-25-016833 | May 14, 2025 | Mar 31, 2025 |
| UPLOAD | — | 0000000000-25-004662 | May 1, 2025 | — |
| DRS | — | 0001437749-25-013327 | Apr 28, 2025 | — |
| 4 | FORM 4 | 0001437749-25-010224 | Mar 31, 2025 | — |
| ARS | ARS | 0001437749-25-009848 | Mar 28, 2025 | Jun 30, 2024 |
| DEFA14A | FORM DEFA14A | 0001437749-25-009840 | Mar 28, 2025 | — |
| DEF 14A | FORM DEF 14A | 0001437749-25-009836 | Mar 28, 2025 | May 21, 2025 |
| 4 | FORM 4 | 0001437749-25-005873 | Mar 3, 2025 | Feb 28, 2025 |
| 4 | — | 0000912282-25-000223 | Mar 3, 2025 | Feb 5, 2025 |
| 8-K | FORM 8-K | 0001437749-25-003563 | Feb 12, 2025 | — |
| 10-Q | FORM 10-Q | 0001437749-25-003568 | Feb 12, 2025 | Dec 31, 2024 |
| 4 | — | 0000912282-25-000018 | Jan 2, 2025 | Dec 31, 2024 |
| 8-K | FORM 8-K | 0001437749-24-036630 | Dec 4, 2024 | Dec 3, 2024 |
| SC 13G/A | — | 0000935836-24-000670 | Nov 13, 2024 | — |
| 8-K | FORM 8-K | 0001437749-24-034898 | Nov 13, 2024 | Nov 11, 2024 |
| 3 | — | 0000912282-24-000796 | Nov 13, 2024 | Nov 11, 2024 |
| 4 | — | 0000912282-24-000798 | Nov 13, 2024 | Nov 11, 2024 |
| 10-Q | FORM 10-Q | 0001437749-24-034970 | Nov 13, 2024 | Sep 30, 2024 |
| 4 | — | 0000912282-24-000758 | Nov 8, 2024 | Nov 6, 2024 |
| 4 | — | 0000912282-24-000750 | Nov 8, 2024 | Nov 6, 2024 |
| 4 | — | 0000912282-24-000760 | Nov 8, 2024 | Nov 6, 2024 |
| 4 | — | 0000912282-24-000754 | Nov 8, 2024 | Nov 6, 2024 |
| 4 | — | 0000912282-24-000756 | Nov 8, 2024 | Nov 6, 2024 |
| 4 | — | 0000912282-24-000762 | Nov 8, 2024 | Nov 6, 2024 |
| 4 | — | 0000912282-24-000764 | Nov 8, 2024 | Nov 6, 2024 |
| 4/A | — | 0000912282-24-000752 | Nov 8, 2024 | Aug 11, 2023 |
| EFFECT | — | 9999999995-24-003186 | Oct 15, 2024 | — |
| S-3/A | FORM S-3/A | 0001437749-24-031137 | Oct 11, 2024 | — |
| CORRESP | — | 0001437749-24-030802 | Oct 7, 2024 | — |
| UPLOAD | — | 0000000000-24-011170 | Oct 3, 2024 | — |
| 4 | — | 0000912282-24-000682 | Oct 2, 2024 | Sep 30, 2024 |
| 8-K | FORM 8-K | 0001437749-24-030297 | Oct 1, 2024 | — |
| 8-K | FORM 8-K | 0001437749-24-030075 | Sep 26, 2024 | — |
| S-3 | FORM S-3 | 0001437749-24-030073 | Sep 26, 2024 | — |
| 10-K | FORM 10-K | 0001437749-24-030062 | Sep 26, 2024 | Jun 30, 2024 |
| 8-K | FORM 8-K | 0001437749-24-024725 | Aug 6, 2024 | — |
| 4 | — | 0000912282-24-000527 | Jul 2, 2024 | Jun 30, 2024 |
| 8-K | FORM 8-K | 0001437749-24-021296 | Jun 26, 2024 | — |
| 8-K | FORM 8-K | 0001437749-24-020590 | Jun 18, 2024 | Jun 12, 2024 |
| SC 13D/A | SC 13D/A | 0001104659-24-072841 | Jun 18, 2024 | — |
| 4 | OWNERSHIP DOCUMENT | 0001104659-24-072893 | Jun 18, 2024 | Jun 14, 2024 |
| 10-Q | FORM 10-Q | 0001437749-24-017051 | May 15, 2024 | Mar 31, 2024 |
| 8-K | FORM 8-K | 0001437749-24-017058 | May 15, 2024 | — |
| DEFA14A | FORM DEFA14A | 0001437749-24-016004 | May 10, 2024 | — |
| DEF 14A | FORM DEF 14A | 0001437749-24-016003 | May 10, 2024 | Jun 26, 2024 |
| ARS | — | 0001437749-24-016006 | May 10, 2024 | Jun 30, 2023 |
| 4 | — | 0000912282-24-000340 | Apr 2, 2024 | Mar 31, 2024 |
| 10-Q | FORM 10-Q | 0001437749-24-004149 | Feb 14, 2024 | Dec 31, 2023 |
| 8-K | FORM 8-K | 0001437749-24-004155 | Feb 14, 2024 | — |